{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:07:18Z","timestamp":1790644038845,"version":"4.1.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.lpm.2011.01.005","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T08:29:35Z","timestamp":1300264175000},"page":"e237-e247","source":"Crossref","is-referenced-by-count":65,"special_numbering":"P2","title":["Pathophysiology of inflammatory and autoimmune myopathies"],"prefix":"10.1016","volume":"40","author":[{"given":"Marinos C.","family":"Dalakas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2011.01.005_bib0005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.coph.2010.03.001","article-title":"Inflammatory muscle diseases: a critical review on pathogenesis and therapies","volume":"10","author":"Dalakas","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0010","first-page":"241","article-title":"Pathomechanisms of inflammatory myopathies: recent advances and implications for diagnosis and therapies","volume":"4","author":"Schmidt","year":"2010","journal-title":"Exp Opin"},{"key":"10.1016\/j.lpm.2011.01.005_bib0015","doi-asserted-by":"crossref","unstructured":"Dalakas MC. An update on inflammatory and autoimmune myopathies. Neuropathol Appl Neurobiol 2010, doi:10.1111\/j.1365-2990.2010.01153.x.","DOI":"10.1111\/j.1365-2990.2010.01153.x"},{"key":"10.1016\/j.lpm.2011.01.005_bib0020","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","article-title":"Polymyositis, dermatomyositis, and inclusion-body myositis","volume":"325","author":"Dalakas","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2011.01.005_bib0025","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2011.01.005_bib0030","series-title":"Myology","first-page":"1335","article-title":"The polymyositis and dermatomyositis syndrome","author":"Engel","year":"2008"},{"key":"10.1016\/j.lpm.2011.01.005_bib0035","series-title":"Disorders of voluntary muscle (8th Edition)","first-page":"427","article-title":"The inflammatory myopathies","author":"Dalakas","year":"2010"},{"key":"10.1016\/j.lpm.2011.01.005_bib0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1750-3639.2009.00290.x","article-title":"Inclusion-body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation","volume":"19","author":"Askanas","year":"2009","journal-title":"Brain Pathol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.nmd.2007.11.001","article-title":"Sporadic inclusion-body myositis: a continuing puzzle","volume":"18","author":"Needham","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.lpm.2011.01.005_bib0050","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ncpneuro0261","article-title":"Sporadic inclusion-body myositis: diagnosis, pathogenesis and therapeutic strategies","volume":"2","author":"Dalakas","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0055","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ncprheum0140","article-title":"Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies","volume":"4","author":"Dalakas","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0060","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198602063140601","article-title":"Microvascular deposition of complement membrane attack complex in dermatomyositis","volume":"314","author":"Kissel","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2011.01.005_bib0065","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410270402","article-title":"Microvascular changes in early and advanced dermatomyositis: a quantitative study","volume":"27","author":"Emslie-Smith","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0070","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1172\/JCI117520","article-title":"High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments","volume":"94","author":"Basta","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2011.01.005_bib0075","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ana.410370709","article-title":"Immunopathogenesis of inflammatory myopathies","volume":"37","author":"Dalakas","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-5728(95)00122-0","article-title":"Analysis of cytokine expression in muscle in inflammatory myopathies. Duchenne's dystrophy and non-weak controls","volume":"63","author":"Lundberg","year":"1995","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0085","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00005072-199603000-00009","article-title":"Cytokine expression profiles in idiopathic inflammatory myopathies","volume":"55","author":"Tews","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0090","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/jnen\/59.2.164","article-title":"Increased expression of beta-chemokines in muscle of patients with inflammatory myopathies","volume":"59","author":"Confalonieri","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0095","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1212\/WNL.58.12.1779","article-title":"Differential expression of chemokines in inflammatory myopathies","volume":"58","author":"De Bleecker","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2011.01.005_bib0100","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/mus.10462","article-title":"Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies","volume":"28","author":"Figarella-Branger","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2011.01.005_bib0105","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.24977","article-title":"Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle","volume":"60","author":"Mammen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2011.01.005_bib0110","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/jnen\/60.9.847","article-title":"Cathepsins are upregulated by IFN-gamma\/STAT1 in human muscle culture: a possible active factor in dermatomyositis","volume":"60","author":"Gallardo","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0115","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0120","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2011.01.005_bib0125","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.4049\/jimmunol.168.8.4154","article-title":"Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis","volume":"168","author":"Tezak","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0130","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/awh518","article-title":"Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes","volume":"128","author":"Raju","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2011.01.005_bib0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/clim.1999.4823","article-title":"Downregulation of TGF-(1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin","volume":"94","author":"Amemiya","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0140","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/0140-6736(92)91134-T","article-title":"Viruses in the idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle","volume":"339","author":"Leff","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2011.01.005_bib0145","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ana.410320215","article-title":"Absence of persistent infection with enteroviruses in muscles of patients with inflammatory myopathies","volume":"32","author":"Leon-Monzon","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0150","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0167-5699(94)90006-X","article-title":"The immunobiology of muscle","volume":"15","author":"Hohlfeld","year":"1994","journal-title":"Immunol Today"},{"key":"10.1016\/j.lpm.2011.01.005_bib0155","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.it.2005.05.003","article-title":"Immunobiology of muscle: advances in understanding an immunological microenvironment","volume":"26","author":"Wiendl","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410160206","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibres invaded by T cells","volume":"16","author":"Arahata","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0165","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.410230210","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. IV: Cell-mediated cytotoxicity and muscle fiber necrosis","volume":"23","author":"Arahata","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0170","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ana.410160207","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis","volume":"16","author":"Engel","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0175","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0046-8177(86)80180-0","article-title":"Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies","volume":"17","author":"Engel","year":"1986","journal-title":"Hum Pathol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0180","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1172\/JCI118749","article-title":"Differential expression of perforin in muscle-infiltrating T cell in polymyositis and dermatomyositis","volume":"97","author":"Goebels","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2011.01.005_bib0185","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/brain\/awh148","article-title":"Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity","volume":"127","author":"Schmidt","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2011.01.005_bib0190","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ana.410290509","article-title":"Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies","volume":"29","author":"Hohlfeld","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0195","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/brain\/120.6.929","article-title":"Cytotoxic mechanisms in inflammatory myopathies: co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells","volume":"120","author":"Behrens","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2011.01.005_bib0200","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00005072-199612000-00003","article-title":"MHC class I mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: Studies in patients with polymyositis, dermatomyositis, and inclusion body myositis","volume":"55","author":"Schneider","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0205","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.410390122","article-title":"Sporadic inclusion body myositis: counts of different types of abnormal fibers","volume":"39","author":"Pruitt","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0210","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ana.410230111","article-title":"Expression of immunoreactive major histocompatability complex products in human skeletal muscles","volume":"23","author":"Karpati","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0215","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0046-8177(89)90128-7","article-title":"Major histocompatibility complex class I antigen expression, immunologicalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies","volume":"20","author":"Emslie-Smith","year":"1989","journal-title":"Hum Pathol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0220","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1212\/WNL.41.7.1128","article-title":"Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN-gamma","volume":"41","author":"Mantegazza","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2011.01.005_bib0225","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/icb.1990.33","article-title":"Elevated MHC class I and II antigens in cultured human embryonic myoblasts following stimulation with gamma-interferon","volume":"68","author":"Bao","year":"1990","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0230","first-page":"503","article-title":"Induction of HLA-DR expression on human myoblasts with interferon-gamma","volume":"136","author":"Hohlfeld","year":"1990","journal-title":"Am J Pathol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0235","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0960-8966(98)00126-6","article-title":"Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies","volume":"9","author":"De Bleecker","year":"1999","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.lpm.2011.01.005_bib0240","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-5728(03)00218-2","article-title":"Expression of IFN-gamma-inducible chemokines in inclusion body myositis","volume":"141","author":"Raju","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0245","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0165-5728(03)00255-8","article-title":"Muscle inflammation and MHC class I upregulation in muscular dystrophy with lack of dysferlin: an immunopathological study","volume":"142","author":"Confalonieri","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0250","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1084\/jem.181.5.1863","article-title":"T cell receptor in polymyositis: clonal expansion of autoaggressive CD81 T cells","volume":"181","author":"Bender","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.lpm.2011.01.005_bib0255","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1172\/JCI116533","article-title":"Analysis of T cell receptor repertoire of muscle infiltrating T lymphocytes in polymyositis","volume":"91","author":"Mantegazza","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2011.01.005_bib0260","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.4049\/jimmunol.152.5.2569","article-title":"Predominant TCR-alpha-beta variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies","volume":"152","author":"O\u2019Hanlon","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0265","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ana.20293","article-title":"Long-term persistence of clonally expanded T cells in patients with polymyositis","volume":"56","author":"Benveniste","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0270","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1073\/pnas.0236183100","article-title":"Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3-spectratype analysis","volume":"100","author":"Hofbauer","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lpm.2011.01.005_bib0275","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-5728(97)00122-7","article-title":"Oligoclonal expansion of muscle infiltrating T cells in inclusion body myositis","volume":"79","author":"Fyhr","year":"1997","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0280","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0165-5728(97)00246-4","article-title":"T-cell heterogeneity in muscle lesions of inclusion body myositis","volume":"84","author":"Bender","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0285","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.4049\/jimmunol.167.7.4051","article-title":"Clonal biases of peripheral CD8 T cell repertoire directly reflect local inflammation in polymyositis","volume":"167","author":"Nishio","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0290","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/brain\/123.10.2030","article-title":"Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies","volume":"123","author":"Amemiya","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2011.01.005_bib0295","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199103283241303","article-title":"Polymyositis mediated by T lymphocytes that express the gamma\/delta receptor","volume":"324","author":"Hohlfeld","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2011.01.005_bib0300","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1084\/jem.176.6.1785","article-title":"Autoaggressive myocytotoxic T-lymphocytes expressing an unusual gamma delta T cell receptor","volume":"176","author":"Puschke","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.lpm.2011.01.005_bib0305","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4049\/jimmunol.169.1.515","article-title":"An autoreactive gamma delta TCR derived from a polymyositis lesion","volume":"169","author":"Wiendl","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0310","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/brain\/awg114","article-title":"Muscle fibres and cultured muscle cells express the B7.1\/2-related inducible co-stimulatory molecule. ICOSL: implications for the pathogenesis of inflammatory myopathies","volume":"126","author":"Wiendl","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2011.01.005_bib0315","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0002-9440(10)65141-3","article-title":"Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNA in inflammatory myopathies","volume":"155","author":"Murata","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0320","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1212\/WNL.54.1.65","article-title":"Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies","volume":"54","author":"Choi","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2011.01.005_bib0325","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199407000-00008","article-title":"Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy","volume":"53","author":"De Bleecker","year":"1994","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0330","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/brain\/awn053","article-title":"Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle","volume":"131","author":"Schmidt","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2011.01.005_bib0335","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/mus.20649","article-title":"Myeloid dendritic cells in inclusion-body myositis and polymyositis","volume":"35","author":"Greenberg","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2011.01.005_bib0340","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4049\/jimmunol.178.1.547","article-title":"A local antigen-driven humoral response is present in the inflammatory myopathies","volume":"178","author":"Bradshaw","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0345","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","article-title":"Myopathy with antibodies to the signal recognition particle: clinical and pathological features","volume":"73","author":"Miller","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2011.01.005_bib0350","first-page":"692","article-title":"Myositis specific autoantibodies: changing insights in pathophysiology and clinical associations","volume":"6","author":"Hengstman","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0355","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200 and 100kDa proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christofer-Stine","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2011.01.005_bib0360","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/jnnp.2008.168294","article-title":"Toxic and drug-induced myopathies","volume":"80","author":"Dalakas","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2011.01.005_bib0365","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nmd.2006.10.007","article-title":"Progressive myopathy with upregulation of MHC-I associated with statin therapy","volume":"17","author":"Needham","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.lpm.2011.01.005_bib0370","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1212\/WNL.43.6.1265-a","article-title":"Enhanced detection of Congo-red-positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer disease using fluorescence technique","volume":"43","author":"Askanas","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2011.01.005_bib0375","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1212\/01.wnl.0000277527.69388.fe","article-title":"Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM","volume":"70","author":"Chahin","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2011.01.005_bib0380","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00401-009-0564-6","article-title":"p62\/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis","volume":"118","author":"Nogalska","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0385","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1172\/JCI38027","article-title":"Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease","volume":"119","author":"Goldfarb","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2011.01.005_bib0390","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ng718","article-title":"The UDP-N-acetylglucosamine 2-epimerase\/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy","volume":"29","author":"Eisenberg","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.lpm.2011.01.005_bib0395","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1212\/01.wnl.0000192129.65677.87","article-title":"Inflammatory, immune, and viral aspects of inclusion-body myositis","volume":"66","author":"Dalakas","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2011.01.005_bib0400","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.1986.03380170097026","article-title":"Polymyositis in patients with AIDS","volume":"256","author":"Dalakas","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2011.01.005_bib0405","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.410230713","article-title":"Neuromuscular diseases associated with human immunodeficiency virus infection","volume":"23","author":"Dalakas","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0410","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0140-6736(89)91793-5","article-title":"HTLV-1 and polymyositis in Jamaica","volume":"12","author":"Morgan","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2011.01.005_bib0415","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/ana.410290505","article-title":"Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis","volume":"29","author":"Illa","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0420","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/mus.880160411","article-title":"Search for HIV proviral DNA and amplified sequences in the muscle biopsies of patients with HIV-polymyositis","volume":"16","author":"Leon-Monzon","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2011.01.005_bib0425","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/119.6.1887","article-title":"Inclusion body myositis in HIV-I and HTLV-I infected patients","volume":"19","author":"Cupler","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2011.01.005_bib0430","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1086\/344315","article-title":"Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis","volume":"186","author":"Saito","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2011.01.005_bib0435","doi-asserted-by":"crossref","first-page":"10320","DOI":"10.1128\/JVI.78.19.10320-10327.2004","article-title":"Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia\/lymphoma virus type 1-infected patient with sporadic inclusion body myositis","volume":"78","author":"Ozden","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0440","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ana.21103","article-title":"IBM with HIV infection: 4 new cases withclonal expansion of viral-specific T cells","volume":"61","author":"Dalakas","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0445","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0046-8177(98)90425-7","article-title":"Rimmed vacuoles with b-amyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation (post-poliomyelitis muscular atrophy): similarities with inclusion body myositis","volume":"29","author":"Semino-Mora","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0450","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/mus.21471","article-title":"Nature of \u201cTau\u201d immunoreactivity in normal myonuclei and inclusion body myositis","volume":"40","author":"Salajegheh","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2011.01.005_bib0455","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0960-8966(96)00369-0","article-title":"Patterns of abnormal protein expression in target formations and unstructured cores","volume":"6","author":"De Bleecker","year":"1996","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.lpm.2011.01.005_bib0460","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00401-003-0794-y","article-title":"Coexistence of X-linked recessive Emery-Dreifuss muscular dystrophy with inclusion body myositis-like morphology","volume":"104","author":"Fidzianska","year":"2004","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0465","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/brain\/awh052","article-title":"Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients","volume":"127","author":"Selcen","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2011.01.005_bib0470","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnen\/63.5.484","article-title":"Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis","volume":"63","author":"Ferrer","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0475","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1750-3639.2005.tb00504.x","article-title":"Involvement of clusterin and the aggresome in abnormal protein deposits in myofibrillar myopathies and inclusion body myositis","volume":"15","author":"Ferrer","year":"2005","journal-title":"Brain Pathol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0480","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp.2007.131334","article-title":"TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia","volume":"79","author":"Weihl","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2011.01.005_bib0485","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ana.21115","article-title":"Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis","volume":"61","author":"L\u00fcnemann","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0490","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-1-59745-157-4_14","article-title":"Localization and MHC class II presentation of antigens targeted for macroautophagy","volume":"445","author":"Schmid","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0495","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.55.12.1509","article-title":"Molecular immunology and genetics of inflammatory muscle diseases","volume":"55","author":"Dalakas","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ana.21452","article-title":"Molecular links between inflamation and degeneration: Lessons on \u201cNeuroinflammation\u201d using IBM as a model","volume":"64","author":"Dalakas","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0505","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ana.21325","article-title":"Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta","volume":"64","author":"Kitazawa","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0510","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/WNL.54.5.1033","article-title":"AlphaB-crystallin immunolocalization yields new insights into inclusion body myositis","volume":"54","author":"Banwell","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2011.01.005_bib0515","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/jnnp.2009.174276","article-title":"Pro-inflammatory cell stress in sporadic inclusion body myositis muscle: overexpression of alphaB-crystallin is associated with amyloid precursor protein and accumulation of beta-amyloid","volume":"80","author":"Muth","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2011.01.005_bib0520","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nmd.2005.12.008","article-title":"Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future","volume":"16","author":"Dalakas","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.lpm.2011.01.005_bib0525","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrrheum.2010.2","article-title":"Immunotherapy of myositis: issues, concerns and future prospects","volume":"6","author":"Dalakas","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.lpm.2011.01.005_bib0530","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mus.10313","article-title":"Inflammatory myopathies: clinical, diagnostic and therapeutic aspects","volume":"27","author":"Mastalgia","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2011.01.005_bib0535","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"New Engl J Med"},{"key":"10.1016\/j.lpm.2011.01.005_bib0540","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/acr.20219","article-title":"Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series","volume":"62","author":"Valiyil","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.lpm.2011.01.005_bib0545","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.48.3.712","article-title":"The efficacy of high dose intravenous immunoglobulin (IVIg) in patients with inclusion-body myositis (IBM)","volume":"48","author":"Dalakas","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2011.01.005_bib0550","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/mus.21377","article-title":"Dermatomyositis with inclusion body myositis pathology","volume":"40","author":"Layzer","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2011.01.005_bib0555","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/brain\/awp104","article-title":"Effect ofAlemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis","volume":"132","author":"Dalakas","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2011.01.005_bib0560","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2249.2009.04025.x","article-title":"Clinical applications of intravenous immunoglobulins in neurology","volume":"158","author":"Hughes","year":"2009","journal-title":"Clin Exp Immunol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498211000534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498211000534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T19:32:19Z","timestamp":1685993539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498211000534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":112,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0755498211000534"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2011.01.005","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}